bHighlights:/bul liThe study compared prostate cancer mortality rate between subjects invited for a single invitation screening study for Prostate-specific antigen (PSA) and those with no invitation for PSA testing /li liThe CAP clinical trial data indicated that prostate cancer mortality at a median follow-up of 15 years was lesser in groups with single invitation as compared to those with no invitation, but the benefit was small /li liThe absolute ..read more

A simple and easy blood test assessing prostate-specific antigen (PSA), a key marker for medlinkprostate cancer/medlink was found to be both safe and effective when conducted every five years (!--ref1--). Undergoing a straightforward blood test to detect prostate-specific antigen (PSA), a critical marker for prostate cancer, every five years, stands as a safe and effective measure with profound potential to safeguard one's health. h2 PSA Screening for Prostate Cancer /h2 bScreening ..read more

medlinkArtificial Intelligence/medlink successfully detected the emergence of two subtypes within prostate cancer, leading to the identification of two distinct disease categories known as 'evotypes.' These discoveries have the potential to transform the future diagnosis and treatment approaches for prostate cancer. This Cancer Research UK-funded study was published in the journal iCell Genomics/i (!--ref1--). h2Revolutionizing Prostate Cancer Care with AI-Driven Discovery/h2 The ..read more

bHighlights:/bul liA plant-based diet can improve sexual function, urinary health, and hormonal balance in prostate cancer patients/li liPlant-rich foods displayed 8% to 11% better scores in sexual function and 14% better scores for urinary health compared to those with the lowest plant-based intake/li liChallenges the misconception that meat consumption enhances male sexual function/li/ul Prostate cancer is a prevalent and potentially ..read more

Children born to women to undernourished medlinkpregnant women/medlink often face an increased risk of medlinkprostate cancer/medlink in adult life, according to two mice studies published in iScientific Reports/i (!--ref1--). h2Protein-Poor Diet in Pregnancy Linked to Prostate Cancer Risk Among Kids in Adult Stage/h2 In the first study, researchers at Sao Paulo State University (UNESP) in Brazil detected alterations in gene expression that may have been associated with the hormone ..read more

CHRM1, a receptor protein, has been pinpointed by researchers as a crucial factor in the resistance of prostate cancer cells to docetaxel, a widely utilized chemotherapy drug for advanced metastatic cancer. The discovery opens the door to new treatment strategies that could overcome this resistance. This could ultimately help extend the lives of those with prostate cancer, one of the leading causes of cancer deaths among men. The researchers did this by using dicyclomine, a drug that selectively inhibits CHRM1 activity ..read more

Our DNA isn't invincible; it breaks due to natural and environmental factors. Fortunately, our bodies repair it using various mechanisms known as DNA repair pathways. Unfortunately, some medlinkcancers/medlink exploit these pathways. Researchers Susanna Stroik, PhD, and Dale Ramsden, PhD, uncovered a lesser-known pathway, polymerase theta-mediated end joining (TMEJ), now linked to hereditary breast, ovarian, and medlinkprostate cancers/medlink with BRCA1 and BRCA2 mutations. Their detailed ..read more

New studies suggest that medlinkinflammation/medlink contributes to the onset of medlinkbenign prostatic hyperplasia/medlink (BPH), stemming from prior infections, metabolic issues, and the condition of the gut microbiota (!--ref1--). h2 Interplay of Lipid Parameters, Metabolic Syndrome, and Interleukins in Benign Prostatic Hyperplasia /h2 In this new study, researchers Weronika Ratajczak, Maria Laszczy (and) #324;ska, Aleksandra Ry (and) #322;, Barbara Do (and) #322; (and) #281;gowska, Olimpia Sipak ..read more

Decitabine, a medlinkprostate cancer/medlink drug, that inhibits DNA methylation, effectively cuts tumor growth in prostate cancer with neuroendocrine features or loss of the gene RB1. DS-7300a- another drug used in prostate cancer treatment, is an antibody-drug conjugate that targets B7-H3 receptors, elevated in prostate tumors. Researchers found that the combination of decitabine and DS-7300a was more effective in slowing the growth of tumors in patients with advanced prostate cancer ..read more

Expansive international team led by USC has conducted the largest and most diverse whole-genome analysis involving nearly 950,000 men on prostate cancer genetics, uncovering 451 genetic variants associated with prostate cancer risk, as published in i Nature Genetics /i (!--ref1--). The research, led by the USC Center for Genetic Epidemiology, the Keck School of Medicine of USC and USC Norris Comprehensive Cancer Center, and in the United Kingdom by The Institute of Cancer Research ..read more